Tag: Meridian Medical Technologies
Pfizer Proposes $345 Million Settlement Over EpiPen Price Gouging
Pfizer and subsidiaries deny any wrongdoing in settlement.
Critical Shortage Forces Australians to Rely on Contaminated and Expired EpiPens
The devices are intended as an emergency treatment for young children who suffer anaphylaxis, a life-threatening allergic reaction.
The Future of EpiPen in Light of the Mylan-Pfizer Deal
An extension to the merger is being contemplated that would consolidate all aspects of the EpiPen business under one company.
Mylan, Marketer of EpiPen, to be Combined with Pfizer's Generics Business
Both companies are subject of a suit alleging an illegal scheme to increase sales of EpiPen.
FDA Confirms Adrenaclick® Generic and EpiPen® Still in Short Supply with...
Shortages of auto-injectors continue. Consider these alternatives.
Epipen Supply Status Update and Extension of Expiration Dates
Tighter supplies and greater variability in pharmacy-level access will potentially continue through the summer months as seasonal demand increases.
Epinephrine Auto-Injector Companies Swept Up in 44 State Price Fixing Lawsuit
State prosecutors describe a price fixing scheme involving more than a dozen companies and as many executives responsible for sales, marketing, and pricing.
EpiPen Shortage Will Continue for Months Longer
A source at Pfizer claims the shortage will continue for an extended time.
Watch: As the EpiPen Shortage Drags On, Chicago Mom Spells Out...
"This Is Literally The Difference Between Life And Death For My Kid."
EpiPen Manufacturer Under Civil Investigation by US Attorney
The company disclosed it was responding to an investigation of quality issues at the facility.
